aurantiamide has been researched along with 3-methylquercetin in 1 studies
| Studies (aurantiamide) | Trials (aurantiamide) | Recent Studies (post-2010) (aurantiamide) | Studies (3-methylquercetin) | Trials (3-methylquercetin) | Recent Studies (post-2010) (3-methylquercetin) |
|---|---|---|---|---|---|
| 8 | 0 | 7 | 464 | 16 | 269 |
| Protein | Taxonomy | aurantiamide (IC50) | 3-methylquercetin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.056 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 1.261 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 2.51 | |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | 6.3 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 6.3 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.017 | |
| Inositol polyphosphate multikinase | Homo sapiens (human) | 2.2 | |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 5 | |
| 3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 8.3 | |
| Aurora kinase B | Homo sapiens (human) | 4.34 | |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, Y; Jia, X; Jiang, Z; Jiao, K; Li, N; Li, X; Wei, H; Zhou, D | 1 |
1 other study(ies) available for aurantiamide and 3-methylquercetin
| Article | Year |
|---|---|
Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.
Topics: Cell Line; Fabaceae; Humans; Inflammation; Lipopolysaccharides; Microglia; Neuroprotective Agents; Plant Extracts | 2017 |